Back to Journals » Patient Preference and Adherence » Volume 4

Patient satisfaction following transition from the original to the new formulation of subcutaneous interferon beta-1a in relapsing multiple sclerosis: a randomized, two-arm, open-label, Phase IIIb study

Total article views   HTML views PDF downloads Totals
7,605 Dovepress* 7,605+ 2,069 9,674
Totals 7,605 2,069 9,674
*Since 6 May 2010
+Since July 2016

View citations on Google Scholar